Connect with us

Politics

Top Federal Drug Official Discusses Rise In Psychedelics Use And The Need To Study Marijuana From Dispensaries

Published

on

Studies demonstrating the therapeutic benefits of psychedelics could be leading more people to experiment with substances like psilocybin, a top federal drug official said in a new interview with Marijuana Moment. And when it comes to cannabis research, she said scientists should be allowed to investigate products from state-legal dispensaries instead of using only government-grown plants.

National Institute on Drug Abuse (NIDA) Director Nora Volkow also spoke in the Thursday interview about the need to decriminalize drug possession and her surprise that teen marijuana use has not increased as more states enact legalization.

Volkow, who closely monitors emerging drug trends, particularly among youth, also discussed a new federal survey reveling that fewer college-aged adults are drinking alcohol and are instead opting for psychedelics and cannabis.

Monitoring the Future (MTF), a long-term epidemiological study, is meant to highlight patterns of behavior for the use of legal and illicit drugs, and its latest iteration found that past-year use of psychedelics like psilocybin and LSD among college students nearly doubled from 2019 to 2020, from five to nine percent.

At the same time, past 30-day alcohol use for that group decreased from 62 percent in 2019 to 56 percent last year. Volkow said the coronavirus pandemic likely helps explain that trend, as young people tend to drink alcohol more in social settings, and the health crisis ground much social interaction to a halt. But what’s to account for the abrupt change in behavior when it comes to psychedelics?

The survey itself doesn’t speculate about the reason for the shift, but Volkow says the surge in research and early clinical trials showing signs that these substances hold significant therapeutic value is a factor. She said people “start to discover the potential that these drugs have,” and they gravitate toward them.

Mainstream media outlets have started to take notice of the psychedelics research renaissance, feeding information to a larger audience that might be enticed by a substance that some studies show effectively addresses conditions like treatment-resistant depression, anxiety and post-traumatic stress disorder.

Volkow also said that she’d be “very surprised” if activist-led efforts to decriminalize or legalize certain psychedelics hasn’t also contributed to the new trend. And the timing makes sense. Denver became the first city in the U.S. to decriminalize psilocybin mushrooms in May 2019—and that set off a wave of reform movements in cities across the U.S. that continue to gain traction and attention.

In other words, there’s a newfound awareness within the general public that psychedelics are generally safe and potentially therapeutic and that laws criminalizing natural plants and fungi are loosening in various jurisdictions.

John Schulenberg, a University of Michigan research who is the principal investigator for MTF, told Marijuana Moment that he agrees with the director’s assessment.

“I think that’s what’s going on here. That is a societal change in terms of the [perception of] danger and possible benefits,” he said. “This is part of what’s happening society—that there are perceptions of the drug’s medicinal purposes, and science seems to be backing it up.”

Marijuana use among college students also increased in 2020, with 44 percent of that demographic reporting past-year cannabis consumption. Volkow again pointed to the COVID-19 crisis as a possible explanation, but it’s also the case that this has been a consistent trend for young adults in recent years.

But notably, that trend has not been observed among teens, with rates of past-year use for high school seniors remaining stable at 35 percent. It’s yet another datapoint that supports what reform advocates have long been arguing: just because more states are legalizing marijuana, that doesn’t mean more young people will start to use it. And in fact, having regulated markets that require proof of age can act as a deterrent.

In another recent interview, Volkow conceded that advocates were “right” that teen cannabis use wouldn’t spike after legalization was enacted. But while that’s encouraging, the official has been a consistent voice pushing for more and more research into marijuana, which is made all the more urgent amid the reform movement.

To that end, the director told Marijuana Moment that scientists have been unnecessarily limited in the source of cannabis they’re permitted to study—and it makes sense to enact a policy change that expands their access to products available in state-legal markets.

“Since dispensaries are selling products that are supposedly very specific for certain characteristics—there is not any one plant—without access to that variety and diversity of plant products, researchers cannot advance that question,” she said.

Volkow touched a wide range of drug policy issues in her conversation with Marijuana Moment. The interview below has been lightly edited for length and clarity.

Marijuana Moment: Looking at the 2020 MTF survey, do you have any thoughts on what might be driving the trend of increased use of psychedelics and marijuana among college students and the decrease in alcohol use at the same time?

Nora Volkow: Based on what we know, the first interpretation that I would make about why alcohol drinking has gone down pretty significantly—and particularly, alcohol drinking to intoxication and alcohol drinking in binging. And it’s among this population, what this is basically telling us, is that young people drink together, they go to bars, they go to a party. And to the extent that in COVID, we’ve been basically isolated, the opportunities for them to be physically in those spaces have gone down. And ergo, drinking has gone down. Whereas marijuana is a more solitary type of drug taking. People use it to relax and to stone themselves out. There are kids that go together, they actually go and smoke together, but it’s not the way that it is in alcohol, that social interaction.

MM: With respect to psychedelics specifically, do you feel like the activist-led push to reform laws governing substances like psilocybin over the past couple years has contributed to the increased use we’re seeing in this survey?

NV: I would be very surprised if he doesn’t influence it because that narrative actually has caught attention. These states are legalizing, so the media writes about it. And people start to discover the potential that these drugs have for therapeutics and the current trials that are ongoing. This takes on a momentum because the ideal world of having a drug that can cure things very dramatically. And there’s always that feel, like a fairy tale, that tells you something that is very appealing, and you immediately embrace it. This is the way that our brain works, we embrace theories that are within what we would like to see, much more than those that we would reject. So yes, I do suspect that it is the case.

I was speaking to my sister yesterday, and she lives in Mexico. And we were discussing the notion and she says, ‘Nora, I cannot go to museums, I cannot see my friends, my life has become very, very boring. And we need to live with this boring life.’ And it’s just occurred to me, that this is my older sister, and she’s complaining that her life has become very boring because of the isolation. How do you compensate for these these exciting activities? Psychedelic drugs is one of them. And so in that respect, it’s a very different drug from the others. It allows you to modify the perception of your environment. If you cannot go to a different environment, you can modify the way that that environment enters into your consciousness.

I think that those two components are facilitating the increase, because the increase was huge. It’s almost double in a one-year period. It’s a gigantic.

MM: The Drug Enforcement Administration (DEA) recently released updated quotas for the production of drugs for scientific use, and they greatly increased the allowed amounts for marijuana and psilocybin. Is that a sign that federal officials are seeing greater interest from researchers in investigating these substances? And if so, what are some of the areas you’d hope to see more research into?

NV: We’ve been working with the DEA and multiple agencies to try to actually address the challenges that have existed all along. Whether we approve or not, these drugs are being used. And if we don’t have access to research that informs us on these drugs, first of all, we cannot comment on what are their effects, if they have negative effects. And the fact that a lot of places are claiming that they have therapeutic potential, it becomes very, very difficult to do research with them. So we are working with the DEA to try to figure out ways that can facilitate doing research and expanding knowledge.

I think that this is actually a response to that. And I’m very grateful that this is happening because it will make it easier for investigators to understand the nature of the problem, but also importantly, to be able to provide the treatment if in case they are needed—if someone intoxicates and has an untoward reaction, that we understand how to treat it. But also the possibility—I mean, again, that’s why we do science—that some of these molecules, chemicals in these drugs, may have therapeutic benefits. If we don’t do research, we’ll never know.

MM: You’ve been a longtime critic of the monopoly on federally authorized marijuana production for studies. DEA also announced it will be approving additional manufacturers, but there are still some who feel strongly that scientists should have access to cannabis products available in state-legal markets. Where do you stand on that?

NV: I think it would be theoretically ideal to understand the actual products that people are consuming, as opposed to trying to understand it with a different compound—a different plant that will vary in terms of the contents of ingredients. And since the dispensaries are selling products that are supposedly very specific for certain characteristics, there is not any one plant so without access to that variety and diversity of plant products, researchers cannot advance that question. That’s something, again, that DEA has to enable, but from the the scientific perspective it would be valuable.

MM: You often discuss the societal consequences of criminalizing drugs, particularly on communities of color that are disproportionately targeted. What do you think would be a superior, alternative model?

NV: I would use what we have learned from other places that have tackled the issue with positive outcomes, and I’m very specifically thinking of Portugal.

I’m not specifically thinking in terms of Portugal as it relates to legalization because, overall, my concern with legalization is that it promotes the growth of a market of a problem which actually is optimized to make people addicted. And that leads to very negative consequences. I’m very concerned about the process of legalization unless there is a very good regulation that ensures that there’s not a profit that drives and jeopardizes the wellbeing of people. I’m very much against it. That’s one of the aspects that I see—I mean, has been so very negative. We pay a huge price with tobacco. How many people died that should have died because of that greed of the industry that’s selling these products?

But when I look at Portugal, what to me is very interesting is that they completely decriminalized—but what they’ve done in parallel is provide a treatment that is necessary. And that’s what we have not done in the United States. So when you say, why would I like to see? Absolutely, I’d like to see decriminalization of the individual that is taking drugs. There is no justification to put them in jail or prison. And in fact, it jeopardizes their outcome. But instead provide them with treatment.

What we do [now] is we throw people in jail, we remove their access to insurance, if they have any through Medicaid, and then they are thrown out. We have no support for reentry. It’s not surprising that leads to terrible outcomes.

MM: What steps can you, or NIDA, take to encourage lawmakers to enact a policy change to that end?

NV: We have a pretty large initiative, in part in partnership with the Arnold Foundation and the Justice Department, to do research that can help us develop strategies that provide alternatives.

MM: You said in a recent interview that advocates were ultimately “right” that state-level legalization wouldn’t increase youth use despite your initial fears. Is there anything else that’s surprised you about the impacts of the reform?

NV: Well, there are several issues that are concerning to me about what we’re seeing. First of all, we’re seeing that it has increased consumption across all ages other than teenagers. It has gone way up. And that includes pregnant women, so certainly that is very concerning. The other issue that is concerning to me, and we have keep an eye on it, is we’re seeing very strong associations between marijuana exposure and suicidal behaviors. And that is concerning. We’ve seen it in men and women, with or without depression. So that is an aspect that will have to be actually aware of.

It was a surprising finding [that past-year teen use has remained stable]. We’re also starting to see an increase in teenagers [who regularly use cannabis], not occasional use. It’s the regular use that is going up, which is the most dangerous, the daily use. And again, this may reflect, as you think about it, the notion that while legalization does not per se affect the likelihood that teenagers may be able to get marijuana because it’s widely available. The legalization, though, may have facilitated the ability to get marijuana right away. That is why we may be seeing this distinction.

We need to actually see what happens with those indicators because, right now amid the COVID pandemic, it’s difficult to judge because teenagers are at home and what we see is parents may have, particularly those that stay at home, have greater supervision of those kids. So, taking drugs is going down. But on the other hand, kids whose parents are out there working, no supervision, this may lead to higher drug consumption. And that’s sort of where we’re seeing. But as it relates to overall regular marijuana, when we go back to whatever normal is, we will get a better idea if these trends keep going up or not.

Mayors Across The U.S. Push Biden And Congress To Legalize Marijuana With A Focus On Racial Equity

Image element courtesy of Kristie Gianopulos.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Sacramento-based senior editor. His work has also appeared in High Times, VICE and attn.

Politics

Maryland Lawmakers Must Override Governor’s Drug Paraphernalia Decriminalization Veto (Op-Ed)

Published

on

“Criminalization, marginalization, isolation, injury and death are all part of a largely preventable cycle of harm.”

By Scott Cecil, Maryland Matters

The writer is a regional ambassador of the Baltimore Harm Reduction Coalition.

At the urging of public health professionals and harm reduction advocates during the 2021 session, the Maryland legislature approved Senate Bill 420 decriminalizing the possession of drug paraphernalia. Gov. Larry Hogan’s (R) decision to veto that bill flies in the face of the expertise of those same public health professionals and harm reduction advocates.

His action constitutes a failure to meaningfully respond to the calls to abolish hyper-criminalization in policing, reimagine public safety in our society and address the crisis of accidental fatal drug overdoses in Maryland.

Because of the veto, in Maryland, the tools which may be used to consume drugs will continue to be illegal to possess and use. This makes them scarcer and encourages people to share them with others, putting them at an elevated risk of contracting bloodborne illnesses and disease such as hepatitis and HIV.

Criminalization of paraphernalia is dangerous for all Marylanders, including those who do not use illicit substances, because it increases the likelihood that the public at large and law enforcement personnel can be directly harmed. Under continued paraphernalia criminalization, people who use drugs will continue to be reluctant to hold onto their supplies due to the fear that the police will use possession of these items as a means to search and arrest them.

With the threat of having to interact with law enforcement personnel, drug users are more likely to dispose of paraphernalia in public spaces. Paraphernalia criminalization laws also put law enforcement personnel at greater risk because they are more likely to be endangered by hidden supplies when interacting with or conducting a search of someone’s body or belongings.

Prohibitive drug paraphernalia laws are ostensibly intended to discourage both drug use and the availability of paraphernalia. Decades of the so-called War on Drugs has shown us that aggressive enforcement and criminalization of drug use have not reduced the rate of drug use in our society nor the availability of drug paraphernalia.

Meanwhile, the rates of infectious diseases and accidental fatal overdose deaths among drug users have surged. Last year, more than 93,000 Americans (including approximately 2,800 people in Maryland) died of accidental fatal drug overdoses.

Decriminalization or paraphernalia is rooted in the harm reduction principle of equipping people to use drugs more safely.

This is positive for everyone in the community—including law enforcement agents, by stemming the spread of infectious disease and lifting the stigma which so dangerously isolates people who use drugs.

By contrast, criminalization, and perceived suspicion of criminal activity—like illicit drug use—is far too often used as a means for law enforcement personnel to target historically marginalized groups, such as people living with mental illnesses and people who are surviving without access to housing. These folks are more likely to be suffering from substance use disorders, thereby placing them at extremely elevated risk of injury or death from drug use.

Criminalization, marginalization, isolation, injury and death are all part of a largely preventable cycle of harm. And criminalization is perhaps the only part of that cycle which can be meaningfully and quickly addressed by public policy and law.

The Maryland legislature understood this when they passed SB420 into law earlier this year. It is unfortunate that Gov. Hogan has failed to acknowledge this reality.

His statement on the veto demonstrates that he either lacks a sufficient understanding of the expertise of public health professionals and harm reduction advocates, or that his decision making on this issue has been clouded by outdated, misleading or simply false drug-warrior misinformation.

It is now up to the Maryland legislature to override his veto.

Maryland must be led down a path which has the greatest chances of success for reducing the risks associated with drug use for all Marylanders (including those who do not use illicit drugs) and stemming the tide of accidental fatal overdoses in Maryland which have reached catastrophic proportions.

This content was republished with permission from Maryland Matters.

Sign up today for the Maryland Matters Memo, a news roundup delivered to your inbox every day—free.

Pennsylvania’s Lieutenant Governor Wants To Process As Many Marijuana Pardons As Possible Before Leaving Office

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Pennsylvania’s Lieutenant Governor Wants To Process As Many Marijuana Pardons As Possible Before Leaving Office

Published

on

The lieutenant governor of Pennsylvania is stepping up his push to get marijuana records cleared, promoting an expedited petition program that he hopes will provide relief to thousands of people negatively impacted by prohibition.

In an interview with KDKA that aired last week, Lt. Gov. John Fetterman (D) said one of his key goals in his final year in office is to ensure that as many eligible people as possible submit applications to have the courts remove their cannabis records and restore opportunities to things like housing, student financial aid and employment.

“I’m a fervent believer in second chances. And one of the things I quickly discovered was that people’s lives were just being ruined by these silly charges, and you have all this unnecessary review [to seal records],” Fetterman, who chairs the state Board of Pardons, said.

“This is a plant that’s legal in many jurisdictions across America, and it’s not a big deal, but you go through your life in many cases a convicted felon, and that excludes you from a lot of opportunities,” he said. “So I developed an expedited review process that I encourage everybody to partake in.”

There are about 20,000 marijuana-related cases in Pennsylvania each year, he said. And some eligible cases go back decades, including one case that recently went through the petition process where a man had a felony conviction on his record for possession of eight ounces of cannabis that dates back to 1975.

“If you’ve got some stupid charge like that on your record, it doesn’t cost anything to apply, and we can get that off your your permanent record,” the lieutenant governor said. “I don’t care how conservative or how liberal you are politically. I don’t think we as a society should be really damaging people’s future for consuming a plant that is now legal in many jurisdictions—and soon will be in Pennsylvania.”

While both Fetterman and Gov. Tom Wolf (D) support mass expungements of cannabis convictions, he said that, right now, this is “the only way to free records.”

But the official is optimistic about the prospect of future reform to both legalize marijuana in the state and provide an even more effective process to get past convictions sealed. He pointed to a legalization bill that was recently filed by a Republican lawmaker as an example of the “evolution towards this” and described the legislation’s introduction as “a quantum leap in acknowledging it.”

For now, however, he’s doing what he can to raise awareness about the expedited petition program under the Pennsylvania Board of Pardons. People with non-violent marijuana convictions can apply for free on the board’s website.

“I’m lieutenant governor for a little over a year, and we want to get as many people free of these silly convictions and charges that are holding the record back,” Fetterman said. “The application doesn’t cost anything. You don’t need an attorney. And our turnaround time is, right now, down to three to four months.”

In May, Wolf pardoned a doctor who was arrested, prosecuted and jailed for growing marijuana that he used to provide relief for his dying wife. That marked his 96th pardon for people with cannabis convictions through the Expedited Review Program for Non-Violent Marijuana-Related Offenses.

Meanwhile in Pennsylvania, a lawmaker introduced a bill last month to expand the number of medical marijuana cultivators in the state, prioritizing small farms to break up what she characterized as a monopoly or large corporations that’s created supply problems.

Separately, bipartisan Pennsylvania senators said this month that they are introducing a bill to allow medical marijuana patients to cultivate their own plants for personal use.

A much-anticipated bipartisan Senate bill to legalize marijuana in Pennsylvania that has been months in the making was formally introduced last month.

Sens. Dan Laughlin (R) and Sharif Street (D) unveiled the nearly 240-page legislation months after first outlining some key details back in February. It would allow adults 21 and older to purchase and possess up to 30 grams of cannabis, five grams of marijuana concentrate products and 500 milligrams of THC contained in cannabis-infused products.

Meanwhile, Rep. Amen Brown (D) recently announced his intent to file a reform bill that he’ll be working on with Sen. Mike Regan (R), who expressed his support for the policy change a day earlier.

Additionally, a separate pair of state lawmakers—Reps. Jake Wheatley (D) and Dan Frankel (D)—formally unveiled a legalization bill they’re proposing.

While each measure generally seeks and end to marijuana criminalization by creating a regulated, commercial model for cannabis, there are some provisions that make each piece of legislation unique. For example, the proposals vary in how they would approach taxes, revenue and social equity.

While these recent moves to enact reform in the GOP-controlled legislature are encouraging to advocates, a spokesperson for House Majority Leader Kerry Benninghoff (R) recently tempered expectations, saying that there’s “no significant support for the legalization of recreational marijuana in the House Republican caucus.”

Fetterman, who is running for U.S. Senate, told Marijuana Moment in a recent phone interview that he’s optimistic about the prospects of reform with these latest proposals, though he acknowledged that there may be disputes between legislators over how tax revenue should be distributed.

Wolf, for his part, has said that a bipartisan approach to legalization “would be a great thing. I think the time is right.”

Philadelphia voters also approved a referendum on marijuana legalization this month that adds a section to the city charter saying that “the citizens of Philadelphia call upon the Pennsylvania General Assembly and the Governor to pass legislation that will decriminalize, regulate, and tax the use, and sale to adults aged 21 years or older, of cannabis for non-medical purposes.”

Wolf said earlier this year that marijuana legalization was a priority as he negotiated the annual budget with lawmakers. However, his formal spending request didn’t contain legislative language to actually accomplish the cannabis policy change.

The governor, who signed a medical cannabis expansion bill in June, has repeatedly called for legalization and pressured the Republican-controlled legislature to pursue the reform since coming out in favor of the policy in 2019. Shortly after he did that, a lawmaker filed a separate bill to legalize marijuana through a state-run model.

A survey from Franklin & Marshall College released this month found that 60 percent of Pennsylvania voters back adult-use legalization. That’s the highest level of support for the issue since the firm started polling people about it in 2006.

An attempt to provide protections for Pennsylvania medical marijuana patients from being charged with driving under the influence was derailed in the legislature last week, apparently due to pushback by the state police association.

Mexican Senators Circulate Draft Marijuana Legalization Bill, With Vote Expected Within Weeks

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Mexican Senators Circulate Draft Marijuana Legalization Bill, With Vote Expected Within Weeks

Published

on

A draft bill to legalize and regulate marijuana sales in Mexico is being circulated among senators, and a top lawmaker says the plan is to vote on the proposal before December 15.

While the legislation hasn’t been formally introduced yet, the draft measure largely reflects an earlier version the Senate passed late last year, with some revisions.

Senate Majority Leader Ricardo Monreal Avila of the ruling MORENA party has been pushing for the reform and recently said that there’s agreement among leading lawmakers to prioritize legislation to regulate cannabis.

The Mexican Supreme Court declared nearly three years ago that the country’s prohibition on the personal possession and cultivation of cannabis was unconstitutional. Lawmakers were then obligated to enact the policy change but have since been unable to reach a consensus on legislation to put in place regulations for a marijuana program.

At the request of legislators, the court agreed to extend its deadline for Congress to formally end prohibition on multiple occasions. But because of the repeated failed attempts to meet those deadlines, justices ultimately voted to end criminalization on their own in June.

Monreal previously said that the stage is set for lawmakers to actually pass a marijuana legalization bill during the new session after multiple attempts in recent years fell short of getting over the finish line.

Under the draft bill that’s currently being circulated, adults 18 and older would be allowed to purchase and possess up to 28 grams of marijuana and cultivate up to six plants for personal use.

Members of the Senate Health and Justice Committees were tapped to formulate the draft of a cannabis bill.

The text of the measure states that the purpose of the reform is to promote “public health, human rights and sustainable development” and to “improve the living conditions of the people who live in the United Mexican States.”

It would further “prevent and combat the consequences of problematic consumption of psychoactive cannabis and contribute to the reduction of the crime incidence linked to drug trafficking, promoting peace, security and individual and community well-being.”

Regulators would be tasked with developing separate rules to regulate cannabis for adult-use, research and industrial production.

The bill would establish a Mexican Institute for the Regulation and Control of Cannabis, which would be a decentralized body under the Ministry of Health. It would also be responsible for issuing licenses, overseeing the program and promoting public education campaigns around marijuana.

Retail licenses would need to be issued within 18 months of the enactment of the law.

In order to “compensate the damages generated by the prohibition,” the bill states that at least 40 percent of marijuana cultivation licenses would need to go to communities most impacted by cannabis criminalization for at least the first five years of implementation. After that point, at least 20 percent of licenses would need to be reserved for equity applicants.

After the Supreme Court independently invalidated prohibition earlier this year, advocates stressed that the decision underscores the need for legislators to expeditiously pass a measure to implement a comprehensive system of legal and regulated sales. They want to ensure that a market is established that’s equitable, addresses the harms of criminalization on certain communities and promotes personal freedom.

Advocates are pleased to see Senate leadership take seriously the need to establish regulations and provide access to cannabis for adults, but they have identified some provisions as problematic.

For example, possessing more than 200 grams of marijuana could still result in prison time.

Senate President Olga Sánchez Cordero, who previously served at a cabinet-level position in President Andrés Manuel López Obrador’s administration, recently said that “there is no longer room for the prohibitionist policy.” And she also says the influence of the U.S. is to blame for failed marijuana criminalization laws in her country.

The Senate approved a legalization bill late last year, and then the Chamber of Deputies made revisions and passed it in March, sending it back to the originating chamber. A couple of Senate committees then took up and cleared the amended measure, but leaders quickly started signaling that certain revisions made the proposal unworkable.

After the Chamber of Deputies previously approved the Senate-passed legalization bill, senators said that the revised proposal was critically internally conflicted—on provisions concerning legal possession limits, the definition of hemp and other issues—and lawmakers themselves could be subject to criminal liability if it went into effect as drafted.

But Monreal said in April that if the court were to make a declaration of unconstitutionality before a measure to regulate cannabis was approved, it would result in “chaos.”

The top senator also talked about the importance of lawmakers taking their time to craft good policy and not rush amidst lobbying from tobacco and pharmaceutical industry interests.

“We must not allow ourselves to be pressured by interests,” he said at the time. “The Senate must act with great prudence in this matter.”

Sen. Eduardo Ramírez Aguilar of the MORENA party said in April that “at this time, it is important to legislate in the terms that are presented to us” and then consider additional revisions to cannabis laws through subsequent bills.

That’s the position many legalization advocates took as well, urging lawmakers to pass an imperfect bill immediately and then work on fixing it later.

Mexico’s president said in December that a vote on legalization legislation was delayed due to minor “mistakes” in the proposal.

The legalization bill cleared a joint group of Senate committees prior to the full floor vote in that chamber last year, with some amendments being made after members informally considered and debated the proposal during a virtual hearing.

Members of the Senate’s Justice, Health, and Legislative Studies Committees had approved a prior version of legal cannabis legislation last year as well, but the pandemic delayed consideration of the issue. Sen. Julio Ramón Menchaca Salazar of the MORENA party said in April that legalizing cannabis could fill treasury coffers at a time when the economy is recovering from the health crisis.

As lawmakers work to advance the reform legislation, there’s been a more lighthearted push to focus attention on the issue by certain members and activists. That push has mostly involved planting and gifting marijuana.

Late last year, Sánchez Cordero, then a top administration official, was gifted a cannabis plant by senator on the Senate floor, and she said she’d be making it a part of her personal garden.

A different lawmaker gave Sánchez Cordero, a marijuana joint on the floor of the Chamber of Deputies in 2019. That joint is now framed and hangs in her office.

Cannabis made another appearance in the legislature last year, when Sen. Jesusa Rodríguez of the MORENA party decorated her desk with a marijuana plant.

Drug policy reform advocates have also been cultivating hundreds of marijuana plants in front of the Senate, putting pressure on legislators to make good on their pledge to advance legalization.

Read the draft marijuana legalization bill that’s being circulated in Mexico’s Senate below: 

Click to access texto-normativo-para-nueva-iniciativa-1.pdf

Taliban Announces Deal To Grow Cannabis In Afghanistan Amid Questions Over Company’s Involvement

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment